Vijaya Diagnostic Centre Ltd. · NSE:VIJAYA

Vijaya Diagnostic Centre — Merger or Acquisition (September 2026)

10 slides from Vijaya Diagnostic Centre's merger presentation, Sep 11, 2026

  1. Slide 1: Regulation 30 filing cover letter to NSE and BSE

    September 11, 2026 To To The Listing Department, The Corporate Relations Department, National Stock Exchange of India Limited BSE Limited NSE Symbol: VIJAYA BSE Scrip Code: 543350 Dear Sir/Madam, Sub: Investor Presentation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements)

  2. Slide 2: Acquisition of Integrated Diagnostic Business (Arya Wellness Centre) in Guwahati, Assam

    Acquisition of Integrated Diagnostic Business (Arya Wellness Centre) in Guwahati, Assam September Q2 & H1 FY25 Earnings Presentation, November 07, 202411, 2026

  3. Slide 3: Safe Harbour

    Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Vijaya Diagnostic Centre Limited (the ‘Company’), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for

  4. Slide 4: About Arya Wellness Centre

    About Arya Wellness Centre Business Overview FY26 Financial Performance ▪ Leading B2C focused integrated diagnostic centre in Guwahati, Assam serving entire North-East market INR 260 Mn ▪ Founded in 2021 as a Joint Venture / AOP between North Revenue from Operations (1) Eastern Medical Research Inst

  5. Slide 5: Brief on the Promoters

    Brief on the Promoters Dr. Bijoya Goswami (NEMRIL) Dr. Anup Das (HRPL) Dr. Pratap Kakati (HRPL) ✔ 40+ years of entrepreneurial ✔ 20+ yrs of post MD experience ✔ 20+ years of experience in experience ✔ MD in Radiology – PGIMER, Histopathology and Cytology ✔ Founder & MD, Arya Hospital Chandigarh ✔ MD

  6. Slide 6: Transaction Consideration and Potential Timelines for the Closure

    Transaction Consideration and Potential Timelines for the Closure Transaction at a Glance Indicative Transaction Timelines TRANSACTION CONSIDERATION ~₹46 Cr 10 Sep 2026 ~Nov / Dec 2026(2) 100% Slump Sale (BTA) CP Satisfaction Business Transfer Business acquisition Transaction structure BTA Signing &

  7. Slide 7: Strategic Rationale for the Acquisition

    Strategic Rationale for the Acquisition Guwahati is a natural extension to our growing presence in West Bengal and provides us with an attractive gateway to the wider North East region Provides immediate access to established operating platform with existing infrastructure, clinical capabilities & r

  8. Slide 8: Management Commentary

    Management Commentary “ Our entry into Guwahati represents another important milestone in Vijaya’s journey towards building a high-quality integrated diagnostics platform. Guwahati is a natural strategic extension of our growing presence in West Bengal and provides us with an attractive gateway to t

  9. Slide 9: Expanding our Footprint with Entry into North-East

    Expanding our Footprint with Entry into North-East Post Existing Acquisition Synergistic Expansion 6 7 States States 166 Established Platform 167 Centres Centres Provides Vijaya with an established operating platform in a strategically synergistic market, strengthening our Eastern India presence and

  10. Slide 10: Thank You

    Thank You For further information please contact: Mr. Dhiren Gala Head - Investor Relations & Corporate Development +91 90598 93206 dhiren.g@vijayadiagnostic.in ir@vijayadiagnostic.in www.vijayadiagnostic.com Corporate Office : #6-3-883/F, FPA Building, Near Topaz Building, Punjagutta, Hyderabad-500

Vijaya Diagnostic Centre — Merger or Acquisition (September 2026) on 6ix